HWM
ROIV icon

Hemington Wealth Management’s Roivant Sciences ROIV Stock Holding History

Hemington Wealth Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3K Buy
246
+189
+332% +$2.34K ﹤0.01% 1281
2025
Q2 		$0 Hold
57
– – ﹤0.01% 1682
2025
Q1 		$0 Sell
57
-14
-20% -$151 ﹤0.01% 1711
2024
Q4 		$0 Sell
71
-33
-32% -$390 ﹤0.01% 1748
2024
Q3 		$1K Buy
+104
New +$1.18K ﹤0.01% 1399

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Hemington Wealth Management's ROIV Position: Q3 2025 in Review

Hemington Wealth Management increased its Roivant Sciences (ROIV) stake by 332% in Q3 2025, buying an estimated $2.34K and bringing the position to 246 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1281.

Hemington Wealth Management first reported a position in ROIV in Q3 2024 and has held it in 5 quarters since. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Hemington Wealth Management held 246 shares of Roivant Sciences worth $3K as of Q3 2025.
  • Hemington Wealth Management bought 189 Roivant Sciences shares in Q3 2025, an estimated $2.34K.
  • Roivant Sciences made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1281 holding.
  • Hemington Wealth Management first reported a position in Roivant Sciences in Q3 2024 and has held it in 5 quarters since.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.